Rank R G, Batteiger B E, Soderberg L S
Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock 72205.
Infect Immun. 1990 Aug;58(8):2599-605. doi: 10.1128/iai.58.8.2599-2605.1990.
Female guinea pigs were immunized with viable or UV light-inactivated chlamydiae (agent of guinea pig inclusion conjunctivitis), belonging to the species Chlamydia psittaci, by intravenous, subcutaneous, oral, or ocular routes. All animals were then inoculated vaginally with viable chlamydiae to determine the extent of protection against challenge infection induced by the various regimens. The course of genital infection was significantly reduced in intensity in all groups of animals except the unimmunized controls and those animals immunized orally with inactivated antigen. Guinea pigs immunized with viable antigen were more likely to develop resistance to challenge infection and, in general, had a significantly greater degree of protection than animals immunized with inactivated antigen. No one route seemed superior in producing a protective response. Animals in all groups demonstrating protection developed serum and secretion immunoglobulin G antibody responses to chlamydiae. Lymphocyte proliferative reactions to chlamydial antigen were variable among groups. Immunoblot analysis of serum and secretions indicated a wide range of antibody specificities, but most protected animals produced antibodies to the major outer membrane protein, lipopolysaccharide, and the 61-kilodalton protein. No definitive associations could be made between the increased ability of immunization with viable organisms to produce resistance to challenge infection and a particular immune parameter. These data indicate that viable chlamydiae given by various routes are able to induce a strong immune response which can provide resistance against reinfection in some cases or at least reduce the degree of infection to a greater degree than inactivated antigen. However, complete resistance to genital tract infection may be difficult to obtain and alternate immunizations strategies may have to be developed.
将豚鼠鹦鹉热衣原体(豚鼠包涵体结膜炎病原体)的活菌体或紫外线灭活菌体通过静脉、皮下、口服或眼部途径免疫雌性豚鼠。然后对所有动物进行阴道接种活衣原体,以确定各种免疫方案对激发感染的保护程度。除未免疫的对照组和口服灭活抗原免疫的动物外,所有动物组的生殖道感染过程强度均显著降低。用活抗原免疫的豚鼠更有可能对激发感染产生抵抗力,总体而言,其保护程度明显高于用灭活抗原免疫的动物。没有一种途径在产生保护性反应方面似乎更具优势。所有显示有保护作用的组中的动物都对衣原体产生了血清和分泌型免疫球蛋白G抗体反应。各实验组对衣原体抗原的淋巴细胞增殖反应各不相同。血清和分泌物的免疫印迹分析表明抗体特异性范围广泛,但大多数受保护的动物产生了针对主要外膜蛋白、脂多糖和61千道尔顿蛋白的抗体。用活生物体免疫产生对激发感染抵抗力的能力增强与特定免疫参数之间无法建立明确的关联。这些数据表明,通过各种途径给予的活衣原体能够诱导强烈的免疫反应,在某些情况下可以提供对再感染的抵抗力,或者至少比灭活抗原更大程度地降低感染程度。然而,可能难以获得对生殖道感染的完全抵抗力,可能必须制定替代免疫策略。